Abstract
Bone morphogenetic proteins (BMPs) are members of the transforming growth factor-β (TGF-β) superfamily of proteins that have crucial roles in growth and regeneration of skeletal tissues. In particular, recombinant human bone morphogenetic protein-2 (rhBMP-2) has been shown to induce new bone formation by differentiation of mesenchymal progenitor cells into osteoblasts (1). BMPs act locally, and thus for a clinically beneficial outcome, a carrier matrix is required to retain therapeutic levels of BMP at the repair site (2,3). The potent osteoinductive ability of BMP-2 has been demonstrated in numerous preclinical (4–9) and clinical studies (10–14). Recent data from clinical trials have reported success in the areas of open fracture repair (10,14), interbody spinal fusion (11), and maxillofacial reconstruction (12,13) using rhBMP-2 delivered in an absorbable collagen sponge (ACS). Because rhBMP-2/ACS requires implantation, there is a continuing need for an easily injectable carrier to deliver rhBMP-2 percutaneously to closed fractures. Here, we outline characterization of a calcium phosphate (CaP)-based injectable carrier as a delivery matrix for rhBMP-2.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Wozney, J. M. (1990) The bone morphogenetic protein family and osteogenesis. Mol. Reprod. Dev. 32, 160–167.
Winn, S. R., Uludag, H., and Hollinger, J. O. (1998) Sustained release emphasizing recombinant human bone morphogenetic protein-2. Adv. Drug Delivery Rev. 31, 303–318.
Li, R. H. and Wozney, J. M. (2001) Delivering on the promise of bone morphogenetic proteins. Trends Biotechnol. 19(7), 255–265.
Gerhart, T. N., Kirker-Head, C. A., Kriz, M. J., et al. (1993) Healing segmental femoral defects in sheep using recombinant human bone morphogenetic protein-2. Clin. Orthop. 293, 317–326.
Hanisch, O., Tatakis, D. H., Rohrer, M.D., et al. (1997) Bone formation and osseointegration stimulated by rhBMP-2 following subantral augmentation procedures in nonhuman primates. Int. J. Oral Maxillofac. Implants 12, 785–792.
Muschler, G. F., Hyodo, A., Manning, T., et al. (1994) Evaluation of human bone morphogenetic protein-2 in a canine fusion model. Clin. Orthop. 308, 229–240.
Sigurdsson, T. J., Lee, M. B., Kubota, K., et al. (1995) Periodontal repair in dogs: recombinant human bone morphogenetic protein-2 significantly enhances periodontal regeneration. J. Periodont. 66, 131–138.
Zegzula, H. D., Buck, D. C., Brekke, J., et al. (1997) Bone formation with use of rhBMP-2 (recombinant human bone morphogenetic protein-2). J. Bone Jt. Surg. Am. 79, 1778–1790.
Bax, B. E., Wozney, J. M., and Ashhurst, D. E. (1999) Bone morphogenetic protein-2 increases the rate of callus formation after fracture of the rabbit tibia. Calcif. Tiss. Int. 65, 83–89.
Riedel, G. E. and Valentin-Opran, A. (1999) Clinical evaluation of rhBMP-2/ACS in orthopedic trauma: a progress report. Orthopedics 22(7), 663–665.
Boden, S. D., Zdeblick, T. A., Sandhu, H. S., and Heim, S. E. (1999) The use of rhBMP-2 in interbody fusion cages: definitive evidence of osteoinduction in humans, in Transactions of the Annual Meeting of the American Academy of Orthopaedic Surgeons, Anaheim, CA, p. 41.
Boyne, P. J., Marx, R. E., Nevins, M., et al. (1997) A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation. International Periodo, J. Resto. Dent. 17(1), 11–25.
Howell, T. H., Fiorellini, J., Jones, A., et al. (1997) A feasibility study evaluating rhBMP-2/absorbable collagen sponge device for local alveolar ridge preservation or augmentation. Int. J. Periodontics Restorative Dent. 17, 124–139.
BESTT (The BMP-2 Evaluation in Surgery for Tibial Trauma Study Group), Govender, S., Csimma, C., et al. (2002) Recombinant human bone morphogenetic protein-2 for open tibial fractures: a prospective, controlled, randomized study in 450 patients. J. Bone and Jt. Surg. 84-A(12), 2123–2134.
Frankenburg, E., Goldstein, S., Bauer, T., Harris, S., and Poser, R. (1998) Biomechanical and histological evaluation of a calcium phosphate cement. J. Bone Jt. Surg. 80-A(8), 1112–1124.
Lobenhoffer, P., Gerich, T., Witte, F., and Tscherne, H. (2002) Use of an injectable calcium phosphate bone cement in the treatment of tibial plateau bone fractures: a prospective study of twenty-six cases with twenty-month mean followup. J. Orthop. Trauma 16(3), 143–149.
Reddi, S., Stevens, M., Kline, S., and Villaneuva, P. (1999) Hydroxyapatite cement in craniofacial trauma surgery: indications and early experience. Craniomaxillofac, J. Trauma 5(1), 7–12.
Heini, P. and Berlemann, U. (2001) Bone substitutes in vertebroplasty. Eur. Spine J. 10(Suppl 2), S205–S213.
Spivak J. and Hasharoni, A. (2001) Use of hydroxyapatite in spine surgery. Eur. Spine J. 10(Suppl 2), S197–S204.
Schmitz, J. P., Hollinger, J. O. and Milam, S. B. (1999) Reconstruction of bone using calcium phosphate bone cements. J. Oral Maxillofac. Surg. 57, 1122–1126.
Lee, D., Tofighi, A., Aiolova, M., et al. (1999) a-BSM: a biomimetic bone substitute and drug delivery vehicle. Clin. Orthop. 367S, S396–S405.
Knaack, D., Goad, E., Aiolova, M., et al. (1997) Novel fully resorbable calcium phosphate bone substitute. J. Bone Miner. Res. 12(1), S202.
Edwards, I., R., Zabka, A., Hayashi, K., et al. (2000) Accelerated fracture healing by percutaneous injection of rhBMP-2 and alpha-BSM, in Transactions of the Annual Meeting of the Orthopaedic Research Society, Orlando, FL., p. 850.
Seeherman, H., Aiolova, M., Bouxsein, M., and Wozney, J. (2001) A single injection of rhBMP-2/calcium phosphate paste accelerates healing in a nonhuman primate osteotomy model, in Transactions of the Annual Meeting of the Orthopaedic Research Society, San Francisco, CA, p. 251.
Hollinger, J., Buck, D., Schmitt, J., et al. (1999) An injectable endothermically-setting calcium phosphate material bridges critical-sized defects in rabbits in combination with rhBMP-2, in Transactions of the Annual Meeting of the Orthopaedic Research Society, Anaheim, CA, p. 509.
Israel, D. I., Nove, J., Kerns, K. M., et al. (1992) Expression and characterization of bone morphogenetic protein-2 in chinese hamster ovary cells. Growth Factors 7, 139–150.
Thies, R. S., Bauduy, M., Ashton, B. A., et al. (1992) Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology 130(3), 1318–1324.
Schenk, R. K., Olah, A.J., and Herrmann, W. (1984) Preparation of calcified tissues for light microscopy, in Methods of Calcified Tissue Preparation (Dickson, G. R., ed.), Elsevier Science, New York, NY, pp. 1–42.
Wozney, J. M., Rosen, V., Celeste, A. J., et al. (1988) Novel regulators of bone formation: molecular clones and activities. Science 242, 1528–1534.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Humana Press Inc.
About this protocol
Cite this protocol
Kim, H.D., Wozney, J.M., Li, R.H. (2004). Characterization of a Calcium Phosphate-Based Matrix for rhBMP-2. In: Hollander, A.P., Hatton, P.V. (eds) Biopolymer Methods in Tissue Engineering. Methods in Molecular Biology™, vol 238. Humana Press. https://doi.org/10.1385/1-59259-428-X:49
Download citation
DOI: https://doi.org/10.1385/1-59259-428-X:49
Publisher Name: Humana Press
Print ISBN: 978-0-89603-967-4
Online ISBN: 978-1-59259-428-3
eBook Packages: Springer Protocols